A survey of factor prophylaxis in the Canadian haemophilia A population
- 1 November 2004
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 10 (6), 679-683
- https://doi.org/10.1111/j.1365-2516.2004.01045.x
Abstract
High-dose factor prophylaxis, defined as the infusion of 25-40 factor (F) VIII International Units (IU) kg bodyweight (bw)(-1)> or = x 3 per week, started at age 1-2 years of life in boys with severe haemophilia A prevents the development of significant bleed-related arthropathy. However, programmes of prophylaxis are very expensive and venous access is a challenge. To ascertain patterns of prophylaxis in Canada during the period of a global shortage of recombinant FVIII concentrate a survey was conducted in 2001. The response rate was 83% and the survey identified 247 inhibitor-negative haemophilia A cases receiving prophylaxis, defined as the regular administration of FVIII at least once weekly, from 14 Canadian haemophilia treatment centres. The median age of the group identified was 13 years (range: 1-65) and 95% of cases had severe haemophilia A defined by a circulating factor level of or = x 3 per week in 67% of cases. High-dose factor prophylaxis was used most frequently in boys 18 years. Prophylaxis accounted for 50% of the annual Canadian FVIII consumption and was a major driving force in the 10% increase (=19.3 million FVIII IU) in the FVIII consumption in Canada in the 4-year period 1999-2003. Given the economic implications of increased use of prophylaxis prospective studies are warranted to better define optimal prophylaxis regimens in the haemophilia A population.Keywords
This publication has 14 references indexed in Scilit:
- A prospective, longitudinal study of central venous catheter‐related deep venous thrombosis in boys with hemophiliaJournal of Thrombosis and Haemostasis, 2004
- Catheter-related deep venous thrombosis in children with hemophiliaBlood, 2001
- The Hemophilias — From Royal Genes to Gene TherapyNew England Journal of Medicine, 2001
- What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?Haemophilia, 2001
- When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10-year single-centre PUP studyEuropean Journal of Pediatrics, 1999
- When should prophylactic treatment in patients with haemophilia A and B start?— The German experienceHaemophilia, 1998
- Port-A-Cath usage in children with haemophilia: experience of 53 casesActa Paediatrica, 1998
- Haemophilia prophylaxis in young patients–a long‐term follow‐upJournal of Internal Medicine, 1997
- A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacsJournal of Internal Medicine, 1994
- Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and BJournal of Internal Medicine, 1992